<DOC>
	<DOCNO>NCT02621125</DOCNO>
	<brief_summary>This double blind , randomize , placebo control clinical trial test efficacy antioxidant formulation Fertilix® lowering level damage sperm DNA men diagnose moderate high Sperm Oxidative DNA Damage ( SODD )</brief_summary>
	<brief_title>Fertilix Supplements Assisted Reproductive Technology</brief_title>
	<detailed_description />
	<criteria>Males sperm sample contain 8OHdG level &gt; 15 % must capable produce ejaculate contain &gt; 10million sperm upon study enrollment . Male 2055 year age seek treatment infertility partner URA candidate IUI , IVF IVFICSI ( exclude donor egg ) procedure . Female 2042 year age Female exhibit tubal patency hydrosonogram hysterosalpingogram ( HSG ) Female exhibit normal uterine cavity hysteroscopy , hydrosonogram hysterosalpingogram ( HSG ) . Exclusion Criteria Subjects initial semen analysis ejaculate contain &lt; 10 million sperm . Men take nutraceuticals , vitamin compound know antioxidant activity within4 week study . No supplement may take Fertilix . Men hypersensitivity allergy ingredient Fertilix® . Men treat chemotherapeutic agent know cause sterility , cyclophosphamide . Men take anabolic steroid testosterone replacement within 4 month study . Men currently treat Ca++ channel blocker medical treatment know adversely affect sperm production function . Men HIV , hepatitis B C .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>